{
  "RESP_META" : {
    "Timing_msec_TOTAL": "22",
    "RUNTIME_OPTIONS": {
      "alwaysAdd": "false",
      "maxDocs": "5000",
      "maxFetch": "5000",
      "texpressAny": "DRUG,HUCELL,HPO,MEASURE,PKPD,DBSNP,CHEMREC,INDICATION,SPMF,BIOCHEM,PROTYP,PHASE,SBIO,TAXON,BIOPROC,CHEMMETH,BIOCHEMPLUS,BAYERPFL,MOA,SAGR,DEVICE,CELLLINE,CHEMSTR,ADVENTMED,PCTOX,GOONTOL,COMPANY,DRUGTYP,BAYERGAF,GENE,MIRNA,LABCHEM,BAYERGAI,ANAT,FOOD",
      "reverse": "true"
    },
    "INPUT_SIZE": 1416,
    "CONID": "76.118.77.27/10519",
    "JSON_PRODUCER": "EFFICIENT",
    "TERMITE_VERS": "6.1.2",
    "REQID": "26c33d17-d50a-4750-9fa6-652fd55a4a2e",
    "HTTP_CODE": "200"
  }
,"RESP_WARNINGS" : null
,"RESP_PAYLOAD":
{}
,"RESP_TEXPRESS": {
  "_document" : {
    "!ANNOTATE": [
      {
        "matches": [],
        "foundEntityTypes": [
          "HPO",
          "ADVENT",
          "ADVENTMED",
          "INDICATION",
          "GENE"
        ],
        "foundEntities": [
          "HPO#HP_0000924",
          "ADVENT#ADVEN05946",
          "ADVENTMED#ADVEN05946",
          "HPO#HP_0000939",
          "INDICATION#D010024",
          "ADVENT#ADVEN05944",
          "ADVENTMED#ADVEN05944",
          "HPO#HP_0000938",
          "INDICATION#D001851",
          "INDICATION#DX90157",
          "GENE#NF1",
          "INDICATION#D009456"
        ],
        "entityNames": {
          "ADVENT#ADVEN05946": "osteoporosis",
          "INDICATION#D009456": "Neurofibromatosis",
          "HPO#HP_0000938": "Osteopenia",
          "HPO#HP_0000924": "Abnormality of the skeletal system",
          "INDICATION#D010024": "Osteoporosis",
          "GENE#NF1": "neurofibromin 1",
          "ADVENTMED#ADVEN05946": "osteoporosis",
          "INDICATION#DX90157": "Osteopenia",
          "INDICATION#D001851": "Metabolic Bone Diseases",
          "HPO#HP_0000939": "Osteoporosis",
          "ADVENT#ADVEN05944": "osteopenia",
          "ADVENTMED#ADVEN05944": "osteopenia"
        },
        "sentenceIndex": 0,
        "wordArray": [
          "skeletal",
          "abnormalities",
          "including",
          "osteoporosis",
          "and",
          "osteopenia",
          "occur",
          "frequently",
          "in",
          "both",
          "pediatric",
          "and",
          "adult",
          "neurofibromatosis",
          "type",
          "1",
          "nf1",
          "patients",
          ""
        ],
        "pseudoAnnotatedArray": [
          "{HPO#HP_0000924}skeletal",
          "_abnormalities",
          "including",
          "{ADVENT#ADVEN05946,ADVENTMED#ADVEN05946,HPO#HP_0000939,INDICATION#D010024}osteoporosis",
          "and",
          "{ADVENT#ADVEN05944,ADVENTMED#ADVEN05944,HPO#HP_0000938,INDICATION#D001851,INDICATION#DX90157}osteopenia",
          "occur",
          "frequently",
          "in",
          "both",
          "pediatric",
          "and",
          "adult",
          "{GENE#NF1,INDICATION#D009456}neurofibromatosis",
          "_type",
          "_1",
          "{GENE#NF1,INDICATION#D009456}nf1",
          "patients",
          ""
        ],
        "originalSentence": "Skeletal abnormalities including osteoporosis and osteopenia occur frequently in both pediatric and adult neurofibromatosis type 1 (NF1) patients.",
        "negCount": 0,
        "charOffset": 0,
        "sectionNumber": 0,
        "sectionCharOffset": 0,
        "sentenceSectionOffset": 0
      },
      {
        "matches": [],
        "foundEntityTypes": [
          "GENE",
          "INDICATION",
          "HUCELL",
          "TAXON",
          "BIOPROC"
        ],
        "foundEntities": [
          "GENE#NF1",
          "INDICATION#D009456",
          "HUCELL#CL0000092",
          "TAXON#TAXON10088",
          "TAXON#TAXON10095",
          "$SCIVERB#EXHIBIT",
          "$SCIVERB#INCREASE",
          "BIOPROC#D002454",
          "$SCIVERB#MIGRATE",
          "BIOPROC#D001862",
          "BIOPROC#BP70297",
          "$SCIVERB#MEDIATE",
          "$SCIVERB#ACTIVATE",
          "GENE#HRAS",
          "$SCIVERB#RESPONSE",
          "$SCIVERB#LIMIT",
          "GENE#CSF1"
        ],
        "entityNames": {
          "INDICATION#D009456": "Neurofibromatosis",
          "$SCIVERB#MIGRATE": "migrate",
          "BIOPROC#D001862": "Bone Resorption",
          "$SCIVERB#LIMIT": "limit",
          "$SCIVERB#EXHIBIT": "exhibit",
          "BIOPROC#D002454": "Cell Differentiation",
          "$SCIVERB#INCREASE": "increase",
          "TAXON#TAXON10095": "Mus sp.",
          "GENE#NF1": "neurofibromin 1",
          "TAXON#TAXON10088": "Mus",
          "GENE#CSF1": "colony stimulating factor 1 (macrophage)",
          "$SCIVERB#MEDIATE": "mediate",
          "GENE#HRAS": "Harvey rat sarcoma viral oncogene homolog",
          "HUCELL#CL0000092": "osteoclast",
          "$SCIVERB#RESPONSE": "response",
          "BIOPROC#BP70297": "in vitro",
          "$SCIVERB#ACTIVATE": "activate"
        },
        "sentenceIndex": 1,
        "wordArray": [
          "nf1",
          "nf1",
          "haploinsufficient",
          "osteoclasts",
          "and",
          "osteoclast",
          "progenitors",
          "derived",
          "from",
          "both",
          "nf1",
          "patients",
          "and",
          "nf1",
          "mice",
          "exhibit",
          "increased",
          "differentiation",
          "migration",
          "and",
          "bone",
          "resorptive",
          "capacity",
          "in",
          "vitro",
          "mediated",
          "by",
          "hyperactivation",
          "of",
          "p21",
          "ras",
          "in",
          "response",
          "to",
          "limiting",
          "concentrations",
          "of",
          "macrophage",
          "colony",
          "stimulating",
          "factor",
          "m",
          "csf",
          ""
        ],
        "pseudoAnnotatedArray": [
          "{GENE#NF1,INDICATION#D009456}nf1",
          "{GENE#NF1,INDICATION#D009456}nf1",
          "haploinsufficient",
          "{HUCELL#CL0000092}osteoclasts",
          "and",
          "{HUCELL#CL0000092}osteoclast",
          "progenitors",
          "derived",
          "from",
          "both",
          "{GENE#NF1,INDICATION#D009456}nf1",
          "patients",
          "and",
          "{GENE#NF1,INDICATION#D009456}nf1",
          "{TAXON#TAXON10088,TAXON#TAXON10095}mice",
          "{$SCIVERB#EXHIBIT}exhibit",
          "{$SCIVERB#INCREASE}increased",
          "{BIOPROC#D002454}differentiation",
          "{$SCIVERB#MIGRATE}migration",
          "and",
          "{BIOPROC#D001862}bone",
          "_resorptive",
          "capacity",
          "{BIOPROC#BP70297}in",
          "_vitro",
          "{$SCIVERB#MEDIATE}mediated",
          "by",
          "{$SCIVERB#ACTIVATE}hyperactivation",
          "of",
          "{GENE#HRAS}p21",
          "_ras",
          "in",
          "{$SCIVERB#RESPONSE}response",
          "to",
          "{$SCIVERB#LIMIT}limiting",
          "concentrations",
          "of",
          "{GENE#CSF1}macrophage",
          "_colony",
          "_stimulating",
          "_factor",
          "{GENE#CSF1}m",
          "_csf",
          ""
        ],
        "originalSentence": "NF1 (Nf1) haploinsufficient osteoclasts and osteoclast progenitors derived from both NF1 patients and Nf1(+/-) mice exhibit increased differentiation, migration, and bone resorptive capacity in vitro, mediated by hyperactivation of p21(Ras) in response to limiting concentrations of macrophage-colony stimulating factor (M-CSF).",
        "negCount": 0,
        "charOffset": 147,
        "sectionNumber": 0,
        "sectionCharOffset": 0,
        "sentenceSectionOffset": 0
      },
      {
        "matches": [],
        "foundEntityTypes": [
          "GENE",
          "INDICATION",
          "HUCELL",
          "GOONTOL",
          "PROTYP"
        ],
        "foundEntities": [
          "GENE#CSF1",
          "$SCIVERB#BIND",
          "GOONTOL#GO0005488",
          "GENE#CSF1R",
          "$SCIVERB#INCREASE",
          "$SCIVERB#ACTIVATE",
          "GENE#NF1",
          "INDICATION#D009456",
          "HUCELL#CL0000092",
          "$SCIVERB#MEDIATE",
          "$SCIVERB#EFFECT",
          "GENE#MAPK3",
          "GOONTOL#GO0004707",
          "GENE#RPS6KA1",
          "PROTYP#PROTYP982"
        ],
        "entityNames": {
          "INDICATION#D009456": "Neurofibromatosis",
          "$SCIVERB#EFFECT": "effect",
          "GENE#CSF1R": "colony stimulating factor 1 receptor",
          "$SCIVERB#BIND": "bind",
          "GOONTOL#GO0004707": "MAP kinase activity",
          "$SCIVERB#INCREASE": "increase",
          "GENE#NF1": "neurofibromin 1",
          "PROTYP#PROTYP982": "ribosomal protein s6 kinase",
          "GENE#CSF1": "colony stimulating factor 1 (macrophage)",
          "$SCIVERB#MEDIATE": "mediate",
          "HUCELL#CL0000092": "osteoclast",
          "GENE#MAPK3": "mitogen-activated protein kinase 3",
          "$SCIVERB#ACTIVATE": "activate",
          "GENE#RPS6KA1": "ribosomal protein S6 kinase, 90kDa, polypeptide 1",
          "GOONTOL#GO0005488": "binding"
        },
        "sentenceIndex": 2,
        "wordArray": [
          "here",
          "we",
          "show",
          "that",
          "m",
          "csf",
          "binding",
          "to",
          "its",
          "receptor",
          "c",
          "fms",
          "results",
          "in",
          "increased",
          "c",
          "fms",
          "activation",
          "in",
          "nf1",
          "osteoclast",
          "progenitors",
          "mediating",
          "multiple",
          "gain",
          "in",
          "functions",
          "through",
          "the",
          "downstream",
          "effectors",
          "erk1",
          "2",
          "and",
          "p90rsk",
          ""
        ],
        "pseudoAnnotatedArray": [
          "here",
          "we",
          "show",
          "that",
          "{GENE#CSF1}m",
          "_csf",
          "{$SCIVERB#BIND,GOONTOL#GO0005488}binding",
          "to",
          "its",
          "receptor",
          "{GENE#CSF1R}c",
          "_fms",
          "results",
          "in",
          "{$SCIVERB#INCREASE}increased",
          "{GENE#CSF1R}c",
          "_fms",
          "{$SCIVERB#ACTIVATE}activation",
          "in",
          "{GENE#NF1,INDICATION#D009456}nf1",
          "{HUCELL#CL0000092}osteoclast",
          "progenitors",
          "{$SCIVERB#MEDIATE}mediating",
          "multiple",
          "gain",
          "in",
          "functions",
          "through",
          "the",
          "downstream",
          "{$SCIVERB#EFFECT}effectors",
          "{GENE#MAPK3}erk1",
          "{*GOONTOL#GO0004707*}2",
          "and",
          "{GENE#RPS6KA1,PROTYP#PROTYP982}p90rsk",
          ""
        ],
        "originalSentence": "Here, we show that M-CSF binding to its receptor, c-Fms, results in increased c-Fms activation in Nf1(+/) (-) osteoclast progenitors, mediating multiple gain-in-functions through the downstream effectors Erk1/2 and p90RSK.",
        "negCount": 0,
        "charOffset": 476,
        "sectionNumber": 0,
        "sectionCharOffset": 0,
        "sentenceSectionOffset": 0
      },
      {
        "matches": [],
        "foundEntityTypes": [
          "BIOCHEMPLUS",
          "DRUG",
          "BIOPROC",
          "GENE",
          "INDICATION",
          "HUCELL",
          "MEASURE"
        ],
        "foundEntities": [
          "BIOCHEMPLUS#C000600259",
          "DRUG#PHRM6E2E209763C66AA56160FD4E2B7DE45B",
          "BIOPROC#BP70448",
          "GENE#CSF1R",
          "$SCIVERB#INHIBIT",
          "MOA#MOA4",
          "SBIO#SBIO00287",
          "$SCIVERB#ATTENUATE",
          "GENE#CSF1",
          "$SCIVERB#MEDIATE",
          "GENE#NF1",
          "INDICATION#D009456",
          "HUCELL#CL0000092",
          "$SCIVERB#MIGRATE",
          "MEASURE#PERCENT@50",
          "BIOPROC#BP70080",
          "MEASURE#PERCENT@70",
          "MEASURE#PERCENT@60"
        ],
        "entityNames": {
          "INDICATION#D009456": "Neurofibromatosis",
          "BIOPROC#BP70080": "adherence",
          "DRUG#PHRM6E2E209763C66AA56160FD4E2B7DE45B": "PLX 3397",
          "GENE#CSF1R": "colony stimulating factor 1 receptor",
          "BIOCHEMPLUS#C000600259": "5-((5-chloro-1H-pyrrolo(2,3-b)pyridin-3-yl)methyl)-N-((6-(trifluoromethyl)pyridin-3-yl)methyl)pyridin-2-amine",
          "$SCIVERB#MIGRATE": "migrate",
          "MEASURE#PERCENT@70": "70%",
          "SBIO#SBIO00287": "Inhibitor",
          "MEASURE#PERCENT@60": "60%",
          "MEASURE#PERCENT@50": "50%",
          "BIOPROC#BP70448": "potent",
          "GENE#NF1": "neurofibromin 1",
          "GENE#CSF1": "colony stimulating factor 1 (macrophage)",
          "$SCIVERB#MEDIATE": "mediate",
          "$SCIVERB#INHIBIT": "inhibit",
          "$SCIVERB#ATTENUATE": "attenuate",
          "HUCELL#CL0000092": "osteoclast",
          "MOA#MOA4": "Inhibitor"
        },
        "sentenceIndex": 3,
        "wordArray": [
          "plx3397",
          "a",
          "potent",
          "and",
          "selective",
          "c",
          "fms",
          "inhibitor",
          "attenuated",
          "m",
          "csf",
          "mediated",
          "nf1",
          "osteoclast",
          "migration",
          "by",
          "50%",
          "adhesion",
          "by",
          "70%",
          "and",
          "pit",
          "formation",
          "by",
          "60%",
          ""
        ],
        "pseudoAnnotatedArray": [
          "{BIOCHEMPLUS#C000600259,DRUG#PHRM6E2E209763C66AA56160FD4E2B7DE45B}plx3397",
          "a",
          "{BIOPROC#BP70448}potent",
          "and",
          "selective",
          "{GENE#CSF1R}c",
          "_fms",
          "{$SCIVERB#INHIBIT,MOA#MOA4,SBIO#SBIO00287}inhibitor",
          "{$SCIVERB#ATTENUATE}attenuated",
          "{GENE#CSF1}m",
          "_csf",
          "{$SCIVERB#MEDIATE}mediated",
          "{GENE#NF1,INDICATION#D009456}nf1",
          "{HUCELL#CL0000092}osteoclast",
          "{$SCIVERB#MIGRATE}migration",
          "by",
          "{MEASURE#PERCENT@50}50%",
          "{BIOPROC#BP70080}adhesion",
          "by",
          "{MEASURE#PERCENT@70}70%",
          "and",
          "pit",
          "formation",
          "by",
          "{MEASURE#PERCENT@60}60%",
          ""
        ],
        "originalSentence": "PLX3397, a potent and selective c-Fms inhibitor, attenuated M-CSF mediated Nf1(+/-) osteoclast migration by 50%, adhesion by 70%, and pit formation by 60%.",
        "negCount": 0,
        "charOffset": 699,
        "sectionNumber": 0,
        "sectionCharOffset": 0,
        "sentenceSectionOffset": 0
      },
      {
        "matches": [],
        "foundEntityTypes": [
          "BIOPROC",
          "BIOCHEMPLUS",
          "DRUG",
          "GENE",
          "INDICATION",
          "TAXON"
        ],
        "foundEntities": [
          "BIOPROC#BP70298",
          "$SCIVERB#ADMINISTERED",
          "BIOCHEMPLUS#C000600259",
          "DRUG#PHRM6E2E209763C66AA56160FD4E2B7DE45B",
          "GENE#NF1",
          "INDICATION#D009456",
          "INDICATION#D010024",
          "TAXON#TAXON10088",
          "TAXON#TAXON10095",
          "$SCIVERB#INDUCE",
          "$SCIVERB#CHANGE",
          "BIOPROC#D001862"
        ],
        "entityNames": {
          "INDICATION#D009456": "Neurofibromatosis",
          "$SCIVERB#ADMINISTERED": "administered",
          "DRUG#PHRM6E2E209763C66AA56160FD4E2B7DE45B": "PLX 3397",
          "$SCIVERB#INDUCE": "induce",
          "GENE#NF1": "neurofibromin 1",
          "INDICATION#D010024": "Osteoporosis",
          "TAXON#TAXON10088": "Mus",
          "BIOCHEMPLUS#C000600259": "5-((5-chloro-1H-pyrrolo(2,3-b)pyridin-3-yl)methyl)-N-((6-(trifluoromethyl)pyridin-3-yl)methyl)pyridin-2-amine",
          "BIOPROC#BP70298": "in vivo",
          "BIOPROC#D001862": "Bone Resorption",
          "$SCIVERB#CHANGE": "change",
          "TAXON#TAXON10095": "Mus sp."
        },
        "sentenceIndex": 4,
        "wordArray": [
          "in",
          "vivo",
          "we",
          "administered",
          "plx3397",
          "to",
          "nf1",
          "osteoporotic",
          "mice",
          "induced",
          "by",
          "ovariectomy",
          "ovx",
          "and",
          "evaluated",
          "changes",
          "in",
          "bone",
          "mass",
          "and",
          "skeletal",
          "architecture",
          ""
        ],
        "pseudoAnnotatedArray": [
          "{BIOPROC#BP70298}in",
          "_vivo",
          "we",
          "{$SCIVERB#ADMINISTERED}administered",
          "{BIOCHEMPLUS#C000600259,DRUG#PHRM6E2E209763C66AA56160FD4E2B7DE45B}plx3397",
          "to",
          "{GENE#NF1,INDICATION#D009456}nf1",
          "{INDICATION#D010024}osteoporotic",
          "{TAXON#TAXON10088,TAXON#TAXON10095}mice",
          "{$SCIVERB#INDUCE}induced",
          "by",
          "ovariectomy",
          "ovx",
          "and",
          "evaluated",
          "{$SCIVERB#CHANGE}changes",
          "in",
          "{BIOPROC#D001862}bone",
          "_mass",
          "and",
          "skeletal",
          "architecture",
          ""
        ],
        "originalSentence": "In vivo, we administered PLX3397 to Nf1(+/-) osteoporotic mice induced by ovariectomy (OVX) and evaluated changes in bone mass and skeletal architecture.",
        "negCount": 0,
        "charOffset": 855,
        "sectionNumber": 0,
        "sectionCharOffset": 0,
        "sentenceSectionOffset": 0
      },
      {
        "matches": [],
        "foundEntityTypes": [
          "BIOCHEMPLUS",
          "DRUG",
          "ADVENT",
          "ADVENTMED",
          "BIOPROC",
          "GENE",
          "INDICATION",
          "TAXON",
          "GOONTOL"
        ],
        "foundEntities": [
          "BIOCHEMPLUS#C000600259",
          "DRUG#PHRM6E2E209763C66AA56160FD4E2B7DE45B",
          "$SCIVERB#PREVENT",
          "ADVENT#ADVEN01201",
          "ADVENTMED#ADVEN01201",
          "BIOPROC#D001862",
          "GENE#NF1",
          "INDICATION#D009456",
          "TAXON#TAXON10088",
          "TAXON#TAXON10095",
          "$SCIVERB#REDUCE",
          "GOONTOL#GO0030316",
          "BIOPROC#BP70298"
        ],
        "entityNames": {
          "$SCIVERB#PREVENT": "prevent",
          "INDICATION#D009456": "Neurofibromatosis",
          "DRUG#PHRM6E2E209763C66AA56160FD4E2B7DE45B": "PLX 3397",
          "GOONTOL#GO0030316": "osteoclast differentiation",
          "BIOCHEMPLUS#C000600259": "5-((5-chloro-1H-pyrrolo(2,3-b)pyridin-3-yl)methyl)-N-((6-(trifluoromethyl)pyridin-3-yl)methyl)pyridin-2-amine",
          "BIOPROC#D001862": "Bone Resorption",
          "ADVENTMED#ADVEN01201": "bone loss",
          "TAXON#TAXON10095": "Mus sp.",
          "ADVENT#ADVEN01201": "bone loss",
          "GENE#NF1": "neurofibromin 1",
          "TAXON#TAXON10088": "Mus",
          "$SCIVERB#REDUCE": "reduce",
          "BIOPROC#BP70298": "in vivo"
        },
        "sentenceIndex": 5,
        "wordArray": [
          "we",
          "found",
          "that",
          "plx3397",
          "prevented",
          "bone",
          "loss",
          "in",
          "nf1",
          "ovx",
          "mice",
          "by",
          "reducing",
          "osteoclast",
          "differentiation",
          "and",
          "bone",
          "resorptive",
          "activity",
          "in",
          "vivo",
          ""
        ],
        "pseudoAnnotatedArray": [
          "we",
          "found",
          "that",
          "{BIOCHEMPLUS#C000600259,DRUG#PHRM6E2E209763C66AA56160FD4E2B7DE45B}plx3397",
          "{$SCIVERB#PREVENT}prevented",
          "{ADVENT#ADVEN01201,ADVENTMED#ADVEN01201,BIOPROC#D001862}bone",
          "_loss",
          "in",
          "{GENE#NF1,INDICATION#D009456}nf1",
          "ovx",
          "{TAXON#TAXON10088,TAXON#TAXON10095}mice",
          "by",
          "{$SCIVERB#REDUCE}reducing",
          "{GOONTOL#GO0030316}osteoclast",
          "_differentiation",
          "and",
          "{BIOPROC#D001862}bone",
          "_resorptive",
          "activity",
          "{BIOPROC#BP70298}in",
          "_vivo",
          ""
        ],
        "originalSentence": "We found that PLX3397 prevented bone loss in Nf1(+/-)-OVX mice by reducing osteoclast differentiation and bone resorptive activity in vivo.",
        "negCount": 0,
        "charOffset": 1009,
        "sectionNumber": 0,
        "sectionCharOffset": 0,
        "sentenceSectionOffset": 0
      },
      {
        "matches": [],
        "foundEntityTypes": [
          "GENE",
          "BIOPROC",
          "INDICATION",
          "HUCELL",
          "SBIO",
          "ADVENT",
          "ADVENTMED",
          "HPO"
        ],
        "foundEntities": [
          "GENE#CSF1",
          "GENE#CSF1R",
          "BIOPROC#D015398",
          "GENE#NF1",
          "INDICATION#D009456",
          "HUCELL#CL0000092",
          "BIOPROC#BP71232",
          "SBIO#SBIO00063",
          "$SCIVERB#TREAT",
          "$SCIVERB#ASSOCIATE",
          "ADVENT#ADVEN05946",
          "ADVENTMED#ADVEN05946",
          "HPO#HP_0000939",
          "INDICATION#D010024",
          "ADVENT#ADVEN05944",
          "ADVENTMED#ADVEN05944",
          "HPO#HP_0000938",
          "INDICATION#D001851",
          "INDICATION#DX90157"
        ],
        "entityNames": {
          "INDICATION#D009456": "Neurofibromatosis",
          "GENE#CSF1R": "colony stimulating factor 1 receptor",
          "INDICATION#D010024": "Osteoporosis",
          "ADVENTMED#ADVEN05946": "osteoporosis",
          "BIOPROC#D015398": "signaling",
          "ADVENTMED#ADVEN05944": "osteopenia",
          "SBIO#SBIO00063": "Drug Target",
          "ADVENT#ADVEN05946": "osteoporosis",
          "HPO#HP_0000938": "Osteopenia",
          "$SCIVERB#TREAT": "treat",
          "GENE#NF1": "neurofibromin 1",
          "GENE#CSF1": "colony stimulating factor 1 (macrophage)",
          "INDICATION#DX90157": "Osteopenia",
          "INDICATION#D001851": "Metabolic Bone Diseases",
          "HUCELL#CL0000092": "osteoclast",
          "HPO#HP_0000939": "Osteoporosis",
          "ADVENT#ADVEN05944": "osteopenia",
          "BIOPROC#BP71232": "target",
          "$SCIVERB#ASSOCIATE": "associate"
        },
        "sentenceIndex": 6,
        "wordArray": [
          "collectively",
          "these",
          "results",
          "implicate",
          "the",
          "m",
          "csf",
          "c",
          "fms",
          "signaling",
          "axis",
          "as",
          "a",
          "critical",
          "pathway",
          "underlying",
          "the",
          "aberrant",
          "functioning",
          "of",
          "nf1",
          "haploinsufficient",
          "osteoclasts",
          "and",
          "may",
          "provide",
          "a",
          "potential",
          "therapeutic",
          "target",
          "for",
          "treating",
          "nf1",
          "associated",
          "osteoporosis",
          "and",
          "osteopenia",
          ""
        ],
        "pseudoAnnotatedArray": [
          "collectively",
          "these",
          "results",
          "implicate",
          "the",
          "{GENE#CSF1}m",
          "_csf",
          "{GENE#CSF1R}c",
          "_fms",
          "signaling",
          "axis",
          "as",
          "a",
          "critical",
          "{BIOPROC#D015398}pathway",
          "underlying",
          "the",
          "aberrant",
          "functioning",
          "of",
          "{GENE#NF1,INDICATION#D009456}nf1",
          "haploinsufficient",
          "{HUCELL#CL0000092}osteoclasts",
          "and",
          "may",
          "provide",
          "a",
          "potential",
          "{BIOPROC#BP71232,SBIO#SBIO00063}therapeutic",
          "_target",
          "for",
          "{$SCIVERB#TREAT}treating",
          "{GENE#NF1,INDICATION#D009456}nf1",
          "{$SCIVERB#ASSOCIATE}associated",
          "{ADVENT#ADVEN05946,ADVENTMED#ADVEN05946,HPO#HP_0000939,INDICATION#D010024}osteoporosis",
          "and",
          "{ADVENT#ADVEN05944,ADVENTMED#ADVEN05944,HPO#HP_0000938,INDICATION#D001851,INDICATION#DX90157}osteopenia",
          ""
        ],
        "originalSentence": "Collectively, these results implicate the M-CSF/c-Fms signaling axis as a critical pathway underlying the aberrant functioning of Nf1 haploinsufficient osteoclasts and may provide a potential therapeutic target for treating NF1 associated osteoporosis and osteopenia.",
        "negCount": 0,
        "charOffset": 1149,
        "sectionNumber": 0,
        "sectionCharOffset": 0,
        "sentenceSectionOffset": 0
      }
    ]
  }
}

}